Gilead Sciences Stock Price History
GILD Stock | USD 107.51 2.72 2.47% |
Below is the normalized historical share price chart for Gilead Sciences extending back to January 22, 1992. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Gilead Sciences stands at 107.51, as last reported on the 19th of March, with the highest price reaching 109.72 and the lowest price hitting 105.81 during the day.
If you're considering investing in Gilead Stock, it is important to understand the factors that can impact its price. Gilead Sciences appears to be very steady, given 3 months investment horizon. Gilead Sciences holds Efficiency (Sharpe) Ratio of 0.22, which attests that the entity had a 0.22 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Gilead Sciences, which you can use to evaluate the volatility of the firm. Please utilize Gilead Sciences' Risk Adjusted Performance of 0.1815, downside deviation of 1.29, and Market Risk Adjusted Performance of 0.9976 to validate if our risk estimates are consistent with your expectations.
At present, Gilead Sciences' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 61.9 B, whereas Capital Stock is forecasted to decline to about 909 K. . At present, Gilead Sciences' Price Book Value Ratio is projected to drop slightly based on the last few years of reporting. The current year's Price To Operating Cash Flows Ratio is expected to grow to 11.17, whereas Price Earnings To Growth Ratio is projected to grow to (2.49). Gilead Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 22nd of January 1992 | 200 Day MA 86.214 | 50 Day MA 102.3966 | Beta 0.236 |
Gilead |
Sharpe Ratio = 0.2217
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | GILD | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
1.54 actual daily | 13 87% of assets are more volatile |
Expected Return
0.34 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
0.22 actual daily | 17 83% of assets perform better |
Based on monthly moving average Gilead Sciences is performing at about 17% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Gilead Sciences by adding it to a well-diversified portfolio.
Price Book 7.1016 | Enterprise Value Ebitda 34.3747 | Price Sales 4.7741 | Shares Float 1.2 B | Dividend Share 3.08 |
Gilead Sciences Stock Price History Chart
There are several ways to analyze Gilead Stock price data. The simplest method is using a basic Gilead candlestick price chart, which shows Gilead Sciences price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | March 7, 2025 | 116.59 |
Lowest Price | January 8, 2025 | 88.52 |
Gilead Sciences March 19, 2025 Stock Price Synopsis
Various analyses of Gilead Sciences' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Gilead Stock. It can be used to describe the percentage change in the price of Gilead Sciences from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Gilead Stock.Gilead Sciences Price Rate Of Daily Change | 0.98 | |
Gilead Sciences Price Daily Balance Of Power | (0.70) | |
Gilead Sciences Price Action Indicator | (1.61) | |
Gilead Sciences Accumulation Distribution | 422,075 |
Gilead Sciences March 19, 2025 Stock Price Analysis
Gilead Stock Price History Data
The price series of Gilead Sciences for the period between Thu, Dec 19, 2024 and Wed, Mar 19, 2025 has a statistical range of 28.07 with a coefficient of variation of 9.44. Under current investment horizon, the daily prices are spread out with arithmetic mean of 99.31. The median price for the last 90 days is 94.92. The company completed 2:1 stock split on 28th of January 2013. Gilead Sciences completed dividends distribution on 2025-03-14.Open | High | Low | Close | Volume | ||
03/19/2025 | 109.69 | 109.72 | 105.81 | 107.51 | 11,844,007 | |
03/18/2025 | 112.19 | 112.20 | 109.84 | 110.23 | 9,892,589 | |
03/17/2025 | 110.93 | 112.56 | 109.46 | 112.26 | 9,258,794 | |
03/14/2025 | 112.89 | 113.36 | 110.90 | 111.44 | 8,644,680 | |
03/13/2025 | 113.00 | 114.67 | 111.91 | 112.56 | 6,939,100 | |
03/12/2025 | 112.36 | 114.07 | 112.03 | 113.20 | 8,065,900 | |
03/11/2025 | 115.84 | 116.16 | 113.13 | 113.63 | 11,478,800 | |
03/10/2025 | 116.18 | 119.12 | 115.97 | 116.39 | 11,194,400 | |
03/07/2025 | 114.84 | 117.59 | 113.99 | 116.59 | 14,406,000 | |
03/06/2025 | 114.66 | 115.50 | 113.81 | 115.23 | 7,712,200 | |
03/05/2025 | 113.94 | 116.39 | 113.70 | 114.64 | 16,088,200 | |
03/04/2025 | 116.43 | 116.57 | 112.79 | 113.94 | 11,982,700 | |
03/03/2025 | 114.09 | 116.34 | 113.88 | 115.18 | 10,017,300 | |
02/28/2025 | 111.37 | 113.97 | 111.03 | 113.51 | 12,604,000 | |
02/27/2025 | 109.56 | 111.79 | 109.28 | 111.21 | 6,301,000 | |
02/26/2025 | 109.94 | 110.30 | 107.64 | 109.69 | 5,911,200 | |
02/25/2025 | 110.33 | 111.33 | 109.33 | 110.75 | 8,072,000 | |
02/24/2025 | 108.81 | 111.21 | 108.69 | 110.26 | 10,495,100 | |
02/21/2025 | 109.96 | 110.26 | 109.00 | 109.18 | 9,732,800 | |
02/20/2025 | 107.03 | 109.34 | 106.68 | 109.26 | 7,684,500 | |
02/19/2025 | 104.50 | 107.06 | 104.47 | 106.90 | 6,384,100 | |
02/18/2025 | 103.52 | 105.84 | 103.28 | 104.52 | 9,434,600 | |
02/14/2025 | 105.06 | 105.95 | 103.20 | 103.35 | 6,400,400 | |
02/13/2025 | 104.11 | 105.69 | 103.10 | 105.22 | 8,715,000 | |
02/12/2025 | 101.03 | 103.98 | 100.13 | 102.59 | 16,210,300 | |
02/11/2025 | 94.67 | 95.61 | 94.37 | 95.47 | 6,260,000 | |
02/10/2025 | 95.37 | 95.50 | 93.90 | 94.81 | 9,628,200 | |
02/07/2025 | 97.08 | 97.64 | 95.23 | 95.37 | 7,182,200 | |
02/06/2025 | 98.85 | 98.90 | 97.17 | 97.36 | 4,518,000 | |
02/05/2025 | 97.79 | 99.81 | 97.33 | 98.96 | 7,738,300 | |
02/04/2025 | 97.69 | 97.78 | 96.37 | 97.31 | 6,156,200 | |
02/03/2025 | 96.35 | 98.76 | 96.07 | 97.69 | 10,515,600 | |
01/31/2025 | 96.06 | 97.68 | 95.76 | 96.52 | 9,419,400 | |
01/30/2025 | 95.89 | 96.29 | 94.77 | 96.27 | 5,020,500 | |
01/29/2025 | 93.74 | 95.26 | 93.42 | 94.92 | 5,593,500 | |
01/28/2025 | 94.34 | 96.03 | 93.16 | 93.20 | 7,406,100 | |
01/27/2025 | 92.45 | 95.17 | 92.45 | 94.69 | 7,914,200 | |
01/24/2025 | 91.72 | 93.34 | 91.62 | 92.42 | 5,409,200 | |
01/23/2025 | 92.38 | 92.64 | 91.57 | 92.27 | 4,086,100 | |
01/22/2025 | 91.98 | 92.66 | 91.20 | 92.39 | 7,285,700 | |
01/21/2025 | 91.42 | 93.25 | 91.42 | 92.31 | 10,546,000 | |
01/17/2025 | 91.37 | 92.15 | 91.05 | 91.20 | 6,862,200 | |
01/16/2025 | 91.62 | 92.42 | 90.19 | 91.01 | 8,955,300 | |
01/15/2025 | 90.71 | 92.01 | 90.41 | 91.74 | 8,084,400 | |
01/14/2025 | 89.96 | 90.84 | 89.20 | 90.37 | 7,418,300 | |
01/13/2025 | 89.67 | 89.74 | 88.40 | 89.31 | 6,523,300 | |
01/10/2025 | 89.56 | 90.79 | 87.95 | 89.25 | 7,869,700 | |
01/08/2025 | 90.05 | 90.05 | 88.38 | 88.52 | 8,054,200 | |
01/07/2025 | 90.26 | 90.87 | 89.88 | 90.00 | 5,811,900 | |
01/06/2025 | 90.12 | 90.89 | 89.70 | 90.59 | 6,779,400 | |
01/03/2025 | 91.55 | 91.70 | 90.67 | 90.77 | 4,265,200 | |
01/02/2025 | 91.97 | 92.18 | 90.76 | 91.24 | 3,495,200 | |
12/31/2024 | 91.94 | 92.33 | 91.14 | 91.73 | 3,482,500 | |
12/30/2024 | 93.28 | 93.34 | 91.08 | 91.37 | 3,613,200 | |
12/27/2024 | 92.78 | 93.72 | 92.78 | 93.45 | 3,349,300 | |
12/26/2024 | 92.52 | 93.89 | 92.33 | 93.75 | 2,915,400 | |
12/24/2024 | 92.35 | 93.39 | 91.46 | 93.30 | 2,109,100 | |
12/23/2024 | 91.97 | 92.87 | 91.15 | 92.75 | 4,809,500 | |
12/20/2024 | 90.29 | 92.64 | 90.08 | 91.92 | 22,530,200 | |
12/19/2024 | 89.77 | 90.84 | 89.64 | 90.46 | 8,875,200 | |
12/18/2024 | 92.07 | 92.85 | 89.96 | 90.06 | 6,616,100 |
About Gilead Sciences Stock history
Gilead Sciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Gilead is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Gilead Sciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Gilead Sciences stock prices may prove useful in developing a viable investing in Gilead Sciences
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 1.3 B | 1.5 B | |
Net Income Applicable To Common Shares | 5.3 B | 4.9 B |
Gilead Sciences Quarterly Net Working Capital |
|
Gilead Sciences Stock Technical Analysis
Gilead Sciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Headlines Timeline Now
Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
All Next | Launch Module |
Gilead Sciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Gilead Sciences' price direction in advance. Along with the technical and fundamental analysis of Gilead Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Gilead to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.1815 | |||
Jensen Alpha | 0.3218 | |||
Total Risk Alpha | 0.4586 | |||
Sortino Ratio | 0.3022 | |||
Treynor Ratio | 0.9876 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Gilead Stock analysis
When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |